| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Jiangsu Apon Medical Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥14.30 |
| 52 Week High | CN¥27.36 |
| 52 Week Low | CN¥7.98 |
| Beta | 0.25 |
| 1 Month Change | 9.92% |
| 3 Month Change | 53.93% |
| 1 Year Change | -2.39% |
| 3 Year Change | -43.94% |
| 5 Year Change | -36.68% |
| Change since IPO | -1.94% |
Recent News & Updates
Shareholder Returns
| 300753 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 17.8% | 2.7% | 2.2% |
| 1Y | -2.4% | -8.8% | -10.2% |
Return vs Industry: 300753 exceeded the CN Medical Equipment industry which returned -9.1% over the past year.
Return vs Market: 300753 exceeded the CN Market which returned -11.3% over the past year.
Price Volatility
| 300753 volatility | |
|---|---|
| 300753 Average Weekly Movement | 10.7% |
| Medical Equipment Industry Average Movement | 6.4% |
| Market Average Movement | 7.4% |
| 10% most volatile stocks in CN Market | 11.0% |
| 10% least volatile stocks in CN Market | 4.3% |
Stable Share Price: 300753's share price has been volatile over the past 3 months.
Volatility Over Time: 300753's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 670 | Zhi Hui Zhang | www.apon.com.cn |
Jiangsu Apon Medical Technology Co., Ltd. engages in the research and development, production, and sale of medical devices in China. Its principal products include microcomputer injection pumps, disposable injection pumps, wireless analgesia management systems, and pulse oximeters, as well as medical devices, such as sensors in the field of pain management and nasal care sprayers in the field of nasal care.
Jiangsu Apon Medical Technology Co., Ltd. Fundamentals Summary
| 300753 fundamental statistics | |
|---|---|
| Market cap | CN¥1.80b |
| Earnings (TTM) | CN¥8.42m |
| Revenue (TTM) | CN¥415.86m |
214.1x
P/E Ratio4.3x
P/S RatioIs 300753 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300753 income statement (TTM) | |
|---|---|
| Revenue | CN¥415.86m |
| Cost of Revenue | CN¥138.70m |
| Gross Profit | CN¥277.15m |
| Other Expenses | CN¥268.74m |
| Earnings | CN¥8.42m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.067 |
| Gross Margin | 66.65% |
| Net Profit Margin | 2.02% |
| Debt/Equity Ratio | 7.6% |
How did 300753 perform over the long term?
See historical performance and comparison